-
Product Insights
Transcatheter Aortic Valve Replacement (TAVR) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Transcatheter Aortic Valve Replacement Pipeline Products Market Report Overview Transcatheter Aortic Valve Replacement (TAVR), also known as, Transcatheter Aortic Valve Implantation (TAVI), is a minimally invasive procedure used to treat severe aortic valve stenosis by implanting a Transcatheter Heart Valve in a patient's diseased aortic valve. The Transcatheter Aortic Valve Replacement (TAVR) pipeline market research report provides comprehensive information about the TAVR pipeline products with a comparative analysis of the products at various stages of development and information about the...
-
Product Insights
Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Transcatheter Heart Valves Pipeline Market Report Overview Transcatheter heart valves are synthetic valves made from biological tissues surrounded by a steel, cobalt-chromium, or nitinol stent. These valves can be either balloon-expandable or self-expandable. The Transcatheter Heart Valves pipeline market research report provides comprehensive information about the Transcatheter Heart Valves pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress Key Segments Transcatheter Aortic Valve Replacement (TAVR),...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – genital herpes vaccine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry genital herpes vaccine Drug Details Vaccine candidate is under development for the prevention of...
-
Product Insights
Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cervical Cancer Drugs Market Report Overview Most cervical cancer is caused by a virus called human papillomavirus, or HPV. Its symptoms of cervical cancer may include abnormal vaginal bleeding, such as bleeding after sex (vaginal intercourse), bleeding after menopause, bleeding, spotting between periods, and having longer or heavier (menstrual) periods than usual. Key Targets Programmed Cell Death Protein 1, Human Papillomavirus Protein E7, Programmed Cell Death 1 Ligand 1, Human Papillomavirus Protein E6, Cytotoxic T Lymphocyte Protein 4, Vascular Endothelial...
-
Product Insights
Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Oropharyngeal Cancer pipeline drugs market research report provides comprehensive information on the therapeutics under development for Oropharyngeal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Oropharyngeal Cancer...
-
Product Insights
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Head and Neck Cancer Pipeline Drugs Market Report Overview Head and Neck Cancer symptoms include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. Treatment includes chemotherapy and radiation therapy. The Head and Neck Cancer pipeline drugs market research report provides an analysis of the Head and Neck Cancer drugs by stage of development, drug target, mechanism of action (MoA), route...
-
Product Insights
Human Papillomavirus (HPV) Associated Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Risk factors of Human Papillomavirus (HPV) Associated Cancer includes smoking, weakened immune system, long-term oral contraceptive use, and chronic inflammation. The Human Papillomavirus (HPV) Associated Cancer pipeline drugs market research report provides an overview of the Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Human Papillomavirus (HPV) Associated Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule...
-
Product Insights
Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Genital Herpes Pipeline Drugs Market Overview Genital Herpes is a common sexually transmitted infection that affects both men and women. Genital herpes is caused by the herpes simplex virus (HSV). Symptoms include decreased appetite, fever, general sick feeling (malaise), muscle aches in the lower back, buttocks, thighs, or knees and swollen and tender lymph nodes in the groin during an outbreak. Treatment includes antiviral medications. The Genital Herpes - drugs in development research report provides a comprehensive overview on the...
-
Product Insights
Non-Alcoholic Steatohepatitis (NASH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-alcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. NASH can get worse and cause scarring of the liver, which leads to cirrhosis. Symptoms of NASH include fatigue, weight loss for no clear reason, general weakness and an ache in the upper right part of belly. Risk factors include obesity, type 2 diabetes, high cholesterol and high triglycerides and metabolic syndrome. The NASH drugs in development market research report provides comprehensive information on the...
-
Product Insights
Surgical Mesh – Medical Devices Pipeline Assessment, 2020
Surgical Mesh is an implantable device that reinforces the growth of soft tissues. It is also used to support the structures of the body from getting prolapsed. GlobalData's Medical Devices sector report, “Surgical Mesh-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Surgical Meshs pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Surgical Mesh Pipeline Assessment report provides key information and data related...